JPY 511.0
(11.57%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 4.88 Billion JPY | 41.95% |
2022 | 2.82 Billion JPY | -16.73% |
2021 | 4.44 Billion JPY | -2.03% |
2020 | 4.54 Billion JPY | -7.36% |
2019 | 3.42 Billion JPY | 3.03% |
2018 | 4.12 Billion JPY | -0.17% |
2017 | 4.12 Billion JPY | 29.82% |
2016 | 3.33 Billion JPY | 24.81% |
2015 | 2.69 Billion JPY | 28.34% |
2014 | 2.15 Billion JPY | -22.48% |
2013 | 2.71 Billion JPY | 8.81% |
2012 | 2.49 Billion JPY | 93.28% |
2011 | 1.53 Billion JPY | 5.02% |
2010 | 1.21 Billion JPY | -2.8% |
2009 | 1.25 Billion JPY | 121.63% |
2008 | -453 Million JPY | 125.02% |
2007 | -2.12 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 1.2 Billion JPY | 12.83% |
2023 Q2 | 698.52 Million JPY | -7.6% |
2023 FY | - JPY | 41.95% |
2023 Q4 | 1.02 Billion JPY | 109.69% |
2023 Q1 | 755.94 Million JPY | 477.71% |
2023 Q3 | 490.77 Million JPY | -29.74% |
2022 Q3 | 302.24 Million JPY | 68.58% |
2022 Q4 | -200.13 Million JPY | -166.22% |
2022 Q1 | 452.73 Million JPY | -51.41% |
2022 Q2 | 179.29 Million JPY | -60.4% |
2022 FY | - JPY | -16.73% |
2021 Q2 | 1.15 Billion JPY | 10.04% |
2021 Q1 | 1.05 Billion JPY | 56.87% |
2021 Q4 | 931.66 Million JPY | -5.96% |
2021 Q3 | 990.73 Million JPY | -14.29% |
2021 FY | - JPY | -2.03% |
2020 FY | - JPY | -7.36% |
2020 Q1 | 735.15 Million JPY | -26.93% |
2020 Q2 | 1.17 Billion JPY | 60.08% |
2020 Q3 | 1.63 Billion JPY | 38.74% |
2020 Q4 | 669.64 Million JPY | -58.99% |
2019 FY | - JPY | 3.03% |
2019 Q1 | 1.02 Billion JPY | -17.37% |
2019 Q2 | 1.58 Billion JPY | 53.76% |
2019 Q3 | 931.65 Million JPY | -41.12% |
2019 Q4 | 1 Billion JPY | 7.99% |
2018 Q2 | 1.17 Billion JPY | 10.34% |
2018 Q1 | 1.06 Billion JPY | -10.48% |
2018 FY | - JPY | -0.17% |
2018 Q3 | 925.18 Million JPY | -21.43% |
2018 Q4 | 1.24 Billion JPY | 34.62% |
2017 Q4 | 1.19 Billion JPY | 34.58% |
2017 FY | - JPY | 29.82% |
2017 Q3 | 885.77 Million JPY | -20.12% |
2017 Q2 | 1.1 Billion JPY | -10.27% |
2017 Q1 | 1.23 Billion JPY | 54.66% |
2016 Q1 | 623.46 Million JPY | -20.82% |
2016 Q4 | 799.06 Million JPY | -25.82% |
2016 Q3 | 1.07 Billion JPY | 18.77% |
2016 Q2 | 907.03 Million JPY | 45.48% |
2016 FY | - JPY | 24.81% |
2015 Q3 | 679.19 Million JPY | -3.57% |
2015 FY | - JPY | 28.34% |
2015 Q4 | 787.44 Million JPY | 15.94% |
2015 Q2 | 704.31 Million JPY | 26.09% |
2015 Q1 | 558.57 Million JPY | -14.49% |
2014 Q2 | 621.91 Million JPY | 82.03% |
2014 FY | - JPY | -22.48% |
2014 Q3 | 538.35 Million JPY | -13.44% |
2014 Q4 | 653.21 Million JPY | 21.33% |
2014 Q1 | 341.64 Million JPY | -79.12% |
2013 Q1 | 575.7 Million JPY | 1.87% |
2013 Q3 | -142.45 Million JPY | -121.13% |
2013 Q4 | 1.63 Billion JPY | 1248.45% |
2013 Q2 | 674.33 Million JPY | 17.13% |
2013 FY | - JPY | 8.81% |
2012 FY | - JPY | 93.28% |
2012 Q3 | 1.06 Billion JPY | 107.97% |
2012 Q2 | 513.57 Million JPY | 37.07% |
2012 Q1 | 374.67 Million JPY | -4.94% |
2012 Q4 | 565.15 Million JPY | -47.09% |
2011 Q2 | 318.55 Million JPY | 15.99% |
2011 Q3 | 317.22 Million JPY | -0.42% |
2011 Q4 | 394.16 Million JPY | 24.25% |
2011 FY | - JPY | 5.02% |
2011 Q1 | 274.64 Million JPY | -29.06% |
2010 Q3 | 324.81 Million JPY | 1.69% |
2010 Q4 | 387.17 Million JPY | 19.2% |
2010 Q1 | 210.81 Million JPY | -31.9% |
2010 Q2 | 319.39 Million JPY | 51.51% |
2010 FY | - JPY | -2.8% |
2009 Q2 | 304.13 Million JPY | -14.05% |
2009 FY | - JPY | 121.63% |
2009 Q4 | 309.55 Million JPY | 0.77% |
2009 Q3 | 307.18 Million JPY | 1.0% |
2009 Q1 | 353.86 Million JPY | 890.65% |
2008 Q2 | 44.21 Million JPY | 0.0% |
2008 Q3 | 252.41 Million JPY | 470.92% |
2008 FY | - JPY | 125.02% |
2008 Q4 | -44.75 Million JPY | -117.73% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
JINS HOLDINGS Inc. | 10.26 Billion JPY | 52.431% |
Medius Holdings Co., Ltd. | 3.86 Billion JPY | -26.342% |
Ship Healthcare Holdings, Inc. | 31.88 Billion JPY | 84.692% |
JTEC Corporation | 437.18 Million JPY | -1016.37% |
Hogy Medical Co.,Ltd. | 10.77 Billion JPY | 54.709% |
Kawamoto Corporation | 944.44 Million JPY | -416.762% |
Terumo Corporation | 219.66 Billion JPY | 97.778% |
KAINOS Laboratories, Inc. | 1.05 Billion JPY | -362.27% |
JAPAN EYEWEAR HOLDINGS CO LTD | 5.18 Billion JPY | 5.836% |
Sysmex Corporation | 115.67 Billion JPY | 95.781% |
JMS Co.,Ltd. | 3.44 Billion JPY | -41.629% |
Nakanishi Inc. | 32.3 Billion JPY | 84.89% |
Mani, Inc. | 10.69 Billion JPY | 54.383% |
Olympus Corporation | 180.16 Billion JPY | 97.291% |
HOYA Corporation | 260.44 Billion JPY | 98.126% |
Asahi Intecc Co., Ltd. | 31.85 Billion JPY | 84.679% |
Medikit Co.,Ltd. | 6.31 Billion JPY | 22.774% |
Daiken Medical Co., Ltd. | 1.65 Billion JPY | -194.465% |
Menicon Co., Ltd. | 16.9 Billion JPY | 71.121% |
Sincere Co., LTD. | 391 Million JPY | -1148.221% |
Platz Co., Ltd. | 267.15 Million JPY | -1726.88% |
Paramount Bed Holdings Co., Ltd. | 23.4 Billion JPY | 79.151% |
Shofu Inc. | 5.87 Billion JPY | 16.969% |
Shigematsu Works Co., Ltd. | 1.38 Billion JPY | -252.324% |
Nipro Corporation | 81.2 Billion JPY | 93.99% |
ASO International, Inc. | 602.47 Million JPY | -710.084% |